Cargando…
Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165575/ https://www.ncbi.nlm.nih.gov/pubmed/32402475 http://dx.doi.org/10.1016/j.therap.2020.05.001 |
| _version_ | 1783701351688044544 |
|---|---|
| author | Grandvuillemin, Aurélie Fresse, Audrey Cholle, Clément Yamani, Samir Dautriche, Anne |
| author_facet | Grandvuillemin, Aurélie Fresse, Audrey Cholle, Clément Yamani, Samir Dautriche, Anne |
| author_sort | Grandvuillemin, Aurélie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8165575 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81655752021-06-01 Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data Grandvuillemin, Aurélie Fresse, Audrey Cholle, Clément Yamani, Samir Dautriche, Anne Therapie Letter to the Editor Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2020 2020-05-05 /pmc/articles/PMC8165575/ /pubmed/32402475 http://dx.doi.org/10.1016/j.therap.2020.05.001 Text en © 2020 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Grandvuillemin, Aurélie Fresse, Audrey Cholle, Clément Yamani, Samir Dautriche, Anne Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data |
| title | Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data |
| title_full | Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data |
| title_fullStr | Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data |
| title_full_unstemmed | Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data |
| title_short | Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data |
| title_sort | adverse drug reactions of hydroxychloroquine: analysis of french pre-pandemic sars-cov2 pharmacovigilance data |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165575/ https://www.ncbi.nlm.nih.gov/pubmed/32402475 http://dx.doi.org/10.1016/j.therap.2020.05.001 |
| work_keys_str_mv | AT grandvuilleminaurelie adversedrugreactionsofhydroxychloroquineanalysisoffrenchprepandemicsarscov2pharmacovigilancedata AT fresseaudrey adversedrugreactionsofhydroxychloroquineanalysisoffrenchprepandemicsarscov2pharmacovigilancedata AT cholleclement adversedrugreactionsofhydroxychloroquineanalysisoffrenchprepandemicsarscov2pharmacovigilancedata AT yamanisamir adversedrugreactionsofhydroxychloroquineanalysisoffrenchprepandemicsarscov2pharmacovigilancedata AT dautricheanne adversedrugreactionsofhydroxychloroquineanalysisoffrenchprepandemicsarscov2pharmacovigilancedata AT adversedrugreactionsofhydroxychloroquineanalysisoffrenchprepandemicsarscov2pharmacovigilancedata |